AKT1 and Hepatic fibrosis: This indicates that CHLD can regulate the mRNA and protein expression of genes related to the PI3K/Akt/mTOR pathway, affecting the expression of autophagy marker proteins LC3 and p62, preventing the activation of hepatic stellate cells, and inhibiting liver fibrosis (Li et al., 2021).